The GlaxoSmithKline plc (GSK) Rating Reiterate by Natixis

The GlaxoSmithKline plc (GSK) Rating Reiterate by Natixis

GlaxoSmithKline plc (LON:GSK)‘s stock had its “neutral” rating reissued by Natixis in a report issued on Thursday. They currently have a GBX 1,750 ($21.33) price objective on the stock. Natixis’ price target would indicate a potential upside of 7.53% from the stock’s previous close.

Other research analysts have also issued research reports about the company. Citigroup Inc. reissued a “buy” rating and set a GBX 1,800 ($21.94) price objective on shares of GlaxoSmithKline plc in a report on Friday, July 1st. Jefferies Group raised GlaxoSmithKline plc to a “buy” rating and boosted their price objective for the stock from GBX 1,650 ($20.11) to GBX 2,000 ($24.38) in a report on Thursday, July 14th. Goldman Sachs Group Inc. reissued a “buy” rating and set a GBX 1,800 ($21.94) price objective on shares of GlaxoSmithKline plc in a report on Tuesday, July 12th. Bryan, Garnier & Co reissued a “buy” rating on shares of GlaxoSmithKline plc in a report on Thursday, July 28th. Finally, Beaufort Securities reissued a “buy” rating on shares of GlaxoSmithKline plc in a report on Tuesday, August 2nd. Three research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and nine have given a buy rating to the stock. GlaxoSmithKline plc presently has an average rating of “Hold” and an average price target of GBX 1,701.68 ($20.74).

GlaxoSmithKline plc (LON:GSK) opened at 1631.5984 on Thursday. GlaxoSmithKline plc has a 12-month low of GBX 1,277.25 and a 12-month high of GBX 1,745.56. The firm’s 50-day moving average is GBX 1,652.78 and its 200 day moving average is GBX 1,577.18. The company’s market cap is GBX 79.39 billion.

The company also recently disclosed a dividend, which will be paid on Thursday, January 12th. Shareholders of record on Thursday, November 3rd will be issued a GBX 19 ($0.23) dividend. The ex-dividend date is Thursday, November 3rd. This represents a yield of 1.17%.

In other news, insider Sir Andrew P. Witty sold 10,000 shares of the firm’s stock in a transaction on Thursday, October 27th. The stock was sold at an average price of GBX 1,636 ($19.94), for a total transaction of £163,600 ($199,390.62). Also, insider Manvinder Singh Banga purchased 1,750 shares of GlaxoSmithKline plc stock in a transaction dated Wednesday, October 26th. The shares were bought at an average price of GBX 1,643 ($20.02) per share, with a total value of £28,752.50 ($35,042.66).

Related posts

Leave a Comment